Bausch Health Companies Inc. (TSX:BHC)
Canada
· Delayed Price · Currency is CAD 7.33
-0.29 (-3.81%)
At close: Mar 6, 2026
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 10,156 | 9,518 | 8,663 | 8,025 | 8,328 | Upgrade
|
| Other Revenue | 110 | 107 | 94 | 99 | 106 | Upgrade
|
| Revenue | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 | Upgrade
|
| Revenue Growth (YoY) | 6.66% | 9.91% | 7.79% | -3.68% | 5.07% | Upgrade
|
| Cost of Revenue | 3,013 | 2,782 | 2,559 | 2,364 | 2,394 | Upgrade
|
| Gross Profit | 7,253 | 6,843 | 6,198 | 5,760 | 6,040 | Upgrade
|
| Selling, General & Admin | 3,431 | 3,276 | 2,895 | 2,531 | 2,492 | Upgrade
|
| Research & Development | 629 | 616 | 604 | 529 | 465 | Upgrade
|
| Amortization of Goodwill & Intangibles | 1,001 | 1,077 | 1,077 | 1,215 | 1,375 | Upgrade
|
| Other Operating Expenses | - | - | 1 | 1 | - | Upgrade
|
| Operating Expenses | 5,061 | 4,969 | 4,577 | 4,276 | 4,332 | Upgrade
|
| Operating Income | 2,192 | 1,874 | 1,621 | 1,484 | 1,708 | Upgrade
|
| Interest Expense | -1,604 | -1,388 | -1,328 | -1,464 | -1,426 | Upgrade
|
| Interest & Investment Income | 48 | 33 | 26 | 14 | 7 | Upgrade
|
| Currency Exchange Gain (Loss) | -52 | -47 | -52 | -8 | 7 | Upgrade
|
| EBT Excluding Unusual Items | 584 | 472 | 267 | 26 | 296 | Upgrade
|
| Merger & Restructuring Charges | -86 | -36 | -95 | -68 | -73 | Upgrade
|
| Impairment of Goodwill | -145 | - | -493 | -824 | -469 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6 | 10 | 3 | 5 | 2 | Upgrade
|
| Asset Writedown | -8 | -29 | -45 | -10 | -211 | Upgrade
|
| Legal Settlements | -61 | -220 | - | -9 | -356 | Upgrade
|
| Other Unusual Items | 191 | -12 | -80 | 752 | -205 | Upgrade
|
| Pretax Income | 367 | 167 | -390 | -129 | -1,024 | Upgrade
|
| Income Tax Expense | 247 | 239 | 221 | 83 | -87 | Upgrade
|
| Earnings From Continuing Operations | 120 | -72 | -611 | -212 | -937 | Upgrade
|
| Minority Interest in Earnings | 37 | 26 | 19 | -13 | -11 | Upgrade
|
| Net Income | 157 | -46 | -592 | -225 | -948 | Upgrade
|
| Net Income to Common | 157 | -46 | -592 | -225 | -948 | Upgrade
|
| Shares Outstanding (Basic) | 371 | 368 | 365 | 362 | 359 | Upgrade
|
| Shares Outstanding (Diluted) | 375 | 368 | 365 | 362 | 359 | Upgrade
|
| Shares Change (YoY) | 1.90% | 0.85% | 0.80% | 0.86% | 1.10% | Upgrade
|
| EPS (Basic) | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 | Upgrade
|
| EPS (Diluted) | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 | Upgrade
|
| Free Cash Flow | 1,003 | 1,260 | 817 | -946 | 1,157 | Upgrade
|
| Free Cash Flow Per Share | 2.67 | 3.42 | 2.24 | -2.61 | 3.22 | Upgrade
|
| Gross Margin | 70.65% | 71.10% | 70.78% | 70.90% | 71.61% | Upgrade
|
| Operating Margin | 21.35% | 19.47% | 18.51% | 18.27% | 20.25% | Upgrade
|
| Profit Margin | 1.53% | -0.48% | -6.76% | -2.77% | -11.24% | Upgrade
|
| Free Cash Flow Margin | 9.77% | 13.09% | 9.33% | -11.64% | 13.72% | Upgrade
|
| EBITDA | 3,400 | 3,141 | 2,885 | 2,878 | 3,260 | Upgrade
|
| EBITDA Margin | 33.12% | 32.63% | 32.95% | 35.43% | 38.65% | Upgrade
|
| D&A For EBITDA | 1,208 | 1,267 | 1,264 | 1,394 | 1,552 | Upgrade
|
| EBIT | 2,192 | 1,874 | 1,621 | 1,484 | 1,708 | Upgrade
|
| EBIT Margin | 21.35% | 19.47% | 18.51% | 18.27% | 20.25% | Upgrade
|
| Effective Tax Rate | 67.30% | 143.11% | - | - | - | Upgrade
|
| Revenue as Reported | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.